Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | F13A1 | P00488 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | CA4 | P22748 | 2/20 | 0.56 |
| ▸ | CA6 | P23280 | 2/20 | 0.56 |
| ▸ | CA5A | P35218 | 2/20 | 0.56 |
| ▸ | THPO | P40225 | 2/20 | 0.56 |
| ▸ | CA7 | P43166 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.56 |
| ▸ | CASP2 | P42575 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Spermine SCHEMBL25409776 | 1.00 | PAOX (0.76) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL193116 | 0.98 | PAOX (0.73) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Spermidine SCHEMBL10954114 | 0.98 | PAOX (0.80) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Hydrochloric Acid SCHEMBL27789136 | 0.96 | PAOX (0.70) | PAOXKDM4EMAPK1HIF1ACA12 | |
| Hydrochloric Acid SCHEMBL17292784 | 0.96 | PAOX (0.70) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL25229942 | 0.96 | PAOX (0.77) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL22171088 | 0.96 | PAOX (0.69) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL22171096 | 0.96 | PAOX (0.69) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL14259519 | 0.94 | PAOX (0.67) | PAOXKDM4EMAPK1HIF1ACA12 | |
| SCHEMBL183048 | 0.94 | PAOX (0.80) | PAOXKDM4EMAPK1HIF1ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20260028400-A1 | ANTI-ROR1 ANTIBODY AND USE THEREOF | AIMED BIO INC (KR) | 2026-01-29 | — | — | US | claimed |
| EP-4679085-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| EP-4603107-A1 | BIOORTHOGONAL, ANILINIUM BASED CLEAVABLE TETRAZINES | University of Copenhagen (DK) | 2025-08-20 | — | — | EP | claimed |
| EP-4591872-A1 | COMPOSITION COMPRISING LACTOBACILLUS PLANTARUM STRAIN FOR IMPROVING INTESTINAL METABOLITE COMPOSITION | Gi Biome Inc. (KR) | 2025-07-30 | — | — | EP | claimed |
| EP-4563597-A1 | ANTI-ROR1 ANTIBODY AND USE THEREOF | AIMED BIO INC. (KR) | 2025-06-04 | — | — | EP | claimed |
| EP-4551232-A1 | METABOLOMIC IMPROVEMENTS USING RESISTANT STARCH SUPPLEMENTATION | Mcpharma Biotech Inc. (CA) | 2025-05-14 | — | — | EP | claimed |
| EP-4518832-A1 | CHONDROITIN- AND COLLAGEN PEPTIDE-BASED METHODS FOR SLOWING DOWN AGING AND EXTENDING LIFESPAN | Ageless Sciences, Inc. (US) | 2025-03-12 | — | — | EP | claimed |
| US-20250032629-A1 | NOVEL NUCLEOLIN-BINDING PEPTIDE AND USE THEREOF | ANYGEN CO., LTD. (KR) | 2025-01-30 | — | — | US | claimed |
| US-20030119735-A1 | Drug moiety linked to a carrier moiety comprising a homeobox peptide or a fragment or derivative thereof. | CYCLACEL LIMITED OF UNITED KINGDOM | 2003-06-26 | — | — | US | claimed |
| US-6472507-B1 | Carrier based drug delivery system | CYCLACEL LIMITED (GB) | 2002-10-29 | — | — | US | claimed |
| US-20020098236-A1 | Transport vectors | CYCLACEL LIMITED | 2002-07-25 | — | — | US | claimed |
| EP-1135410-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | Cyclacel Limited (GB) | 2001-09-26 | — | — | EP | claimed |
| EP-1093383-A1 | DRUG DELIVERY SYSTEM COMPRISING A HOMEOBOX PEPTIDE | Cyclacel Limited (GB) | 2001-04-25 | — | — | EP | claimed |
| WO-2000029427-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | CYCLACEL LIMITED (GB) | 2000-05-25 | — | — | WO | claimed |
| WO-2000001417-A1 | DELIVERY SYSTEM | CYCLACEL LIMITED (GB) | 2000-01-13 | — | — | WO | claimed |
| EP-0297533-B1 | Novel acetylpolyamine amidohydrolase | KYOWA HAKKO KOGYO KK (JP) | 1994-06-01 | — | — | EP | claimed |
| US-4981788-A | BIOSYNTHESIS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-01-01 | — | — | US | claimed |
| EP-0297533-A2 | Novel acetylpolyamine amidohydrolase | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1989-01-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032629-A1 | NOVEL NUCLEOLIN-BINDING PEPTIDE AND USE THEREOF | NCL, NPM1, HNRNPM | PAOX 3169/4885KDM4E 4795/4885MAPK1 3064/4885 |
| US-20260028400-A1 | ANTI-ROR1 ANTIBODY AND USE THEREOF | RORB, RORC, RORA | PAOX 4481/4885KDM4E 2378/4885MAPK1 2298/4885 |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | GLS, AADAT, FGF23 | PAOX 4517/4885KDM4E 124/4885MAPK1 1697/4885 |
| US-20030119735-A1 | Drug moiety linked to a carrier moiety comprising a homeobox peptide or a fragment or derivative thereof. | CDYL, CDYL2, DAXX | PAOX 980/4885KDM4E 2484/4885MAPK1 4045/4885 |
| US-20020098236-A1 | Transport vectors | SLC47A1, SLC47A2, SLC75A1 | PAOX 4039/4885KDM4E 4696/4885MAPK1 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.